Last reviewed · How we verify

Inactivated Coronavac/Butantan vaccine — Competitive Intelligence Brief

Inactivated Coronavac/Butantan vaccine (Inactivated Coronavac/Butantan vaccine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: inactivated viral vaccine. Area: Immunology.

phase 3 inactivated viral vaccine Immunology Biologic Live · refreshed every 30 min

Target snapshot

Inactivated Coronavac/Butantan vaccine (Inactivated Coronavac/Butantan vaccine) — Federal University of Espirito Santo. An inactivated whole-virus SARS-CoV-2 vaccine that stimulates adaptive immune responses to prevent COVID-19 infection.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Inactivated Coronavac/Butantan vaccine TARGET Inactivated Coronavac/Butantan vaccine Federal University of Espirito Santo phase 3 inactivated viral vaccine
fIPV (0.1mL) IM fIPV (0.1mL) IM Centers for Disease Control and Prevention marketed inactivated viral vaccine poliovirus serotypes 1, 2, and 3
EV71 inactived vaccine(Vero cells) EV71 inactived vaccine(Vero cells) Sinovac Biotech Co., Ltd marketed inactivated viral vaccine Enterovirus 71 (EV71) viral antigens
Inactivated COVID-19 Vaccine Inactivated COVID-19 Vaccine Sinovac Research and Development Co., Ltd. marketed inactivated viral vaccine
IMOVAX Polio™: Inactivated Poliomyelitis Vaccine IMOVAX Polio™: Inactivated Poliomyelitis Vaccine Sanofi Pasteur, a Sanofi Company marketed Inactivated viral vaccine
EV71 Vaccine only EV71 Vaccine only Sinovac Biotech Co., Ltd marketed Inactivated viral vaccine Enterovirus 71 (EV71) viral antigens
FSME-Immune vaccination FSME-Immune vaccination Medical University of Vienna marketed Inactivated viral vaccine Tick-borne encephalitis virus (TBEV) envelope proteins

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (inactivated viral vaccine class)

  1. Sinovac Biotech Co., Ltd · 5 drugs in this class
  2. Sinovac Research and Development Co., Ltd. · 2 drugs in this class
  3. Sanofi Pasteur, a Sanofi Company · 2 drugs in this class
  4. Federal University of Espirito Santo · 1 drug in this class
  5. International Vaccine Institute · 1 drug in this class
  6. MacroGenics · 1 drug in this class
  7. Shandong Province Centers for Disease Control and Prevention · 1 drug in this class
  8. Beijing Chaoyang District Centre for Disease Control and Prevention · 1 drug in this class
  9. Zhejiang Provincial Center for Disease Control and Prevention · 1 drug in this class
  10. Centers for Disease Control and Prevention · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Inactivated Coronavac/Butantan vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/inactivated-coronavac-butantan-vaccine. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: